Zhejiang Wecome Pharmaceutical Company Limited

SZSE:300878 Stock Report

Market Cap: CN¥2.5b

Zhejiang Wecome Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Wecome Pharmaceutical has a total shareholder equity of CN¥1.3B and total debt of CN¥332.2M, which brings its debt-to-equity ratio to 24.9%. Its total assets and total liabilities are CN¥1.8B and CN¥502.8M respectively.

Key information

24.9%

Debt to equity ratio

CN¥332.16m

Debt

Interest coverage ration/a
CashCN¥320.58m
EquityCN¥1.34b
Total liabilitiesCN¥502.79m
Total assetsCN¥1.84b

Recent financial health updates

No updates

Recent updates

Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected

Aug 02
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%

Mar 08
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%

Financial Position Analysis

Short Term Liabilities: 300878's short term assets (CN¥783.9M) exceed its short term liabilities (CN¥175.9M).

Long Term Liabilities: 300878's short term assets (CN¥783.9M) exceed its long term liabilities (CN¥326.9M).


Debt to Equity History and Analysis

Debt Level: 300878's net debt to equity ratio (0.9%) is considered satisfactory.

Reducing Debt: 300878's debt to equity ratio has reduced from 25.7% to 24.9% over the past 5 years.

Debt Coverage: 300878's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 300878's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies